医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Scientist.com Brings Together International Experts and Local Pharmaceutical Thought Leaders at Tokyo Innovation Summit

2019年09月10日 AM04:18
このエントリーをはてなブックマークに追加


 

TOKYO

Scientist.com, the pharmaceutical industry’s largest online marketplace for outsourced research, today announced that it will host a client summit on September 12, 2019 at the Nihonboshi Life Science Hub in Tokyo, Japan. The Scientist.com team, including executive management, will be joined by both international and local pharma industry experts for discussions on digitalization, standardization and other R&D sourcing trends.

“In an increasingly competitive research environment, it is imperative that Japanese pharmaceutical companies embrace more efficient digital approaches to life science research,” said Kevin Lustig, PhD, Founder and CEO of Scientist.com. “The Scientist.com marketplace is helping Japanese research companies standardize and simplify their R&D outsourcing – saving time, reducing costs and ensuring adherence to internal and external policies and regulations. The online marketplace also serves as a regularly updated source of innovative tools and technologies from around the world.”

The one-day, September 12 Tokyo event will include expert discussion on how to take advantage of the latest digital tools to standardize and simplify R&D outsourcing. If you are interested in attending this invite-only event or evening reception, please contact Ryosuke Ishigami at ryosuke@scientist.com.

About Scientist.com

Scientist.com is the world’s leading enterprise gateway marketplace for outsourced R&D. The marketplace simplifies R&D sourcing, saving time and money, reducing risk and providing access to the latest innovative tools and technologies. Scientist.com operates private enterprise marketplaces for most of the world’s major pharmaceutical companies, the Biotechnology Innovation Organization (BIO) and the US National Institutes of Health (NIH). Since its founding in 2007, Scientist.com has raised $32 million from 5AM Ventures, Leerink Transformation Partners and Heritage Provider Network among others. Visit scientist.com to learn more.

Join Scientist.com on social media: YouTube, LinkedIn, Twitter, Facebook and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190909005880/en/

CONTACT

Sean Preci

Director of Communications, Scientist.com

858-455-1300 ext. 401

marketing@scientist.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Seoul Viosys’ Violeds Modules Proven to Disinfect 99% of Airborne Viruses in a Recent Testing Result
  • Aurinia Announces Collaboration and Licensing Agreement with Otsuka Pharmaceutical Co., Ltd. for the Development and Commercialization of Voclosporin in Europe and Japan
  • Kaye推出适用于冷链运输市场的Kaye® Log -80℃ 疫苗温度记录器,以满足COVID-19疫苗储存和运输的要求
  • Kaye® (ケイ)は、COVID-19ワクチンの輸送・保管のニーズに応えるためにKaye® ログ -80ワクチン温度ロガーを、コールドチェーン市場向けに導入(発売)します。
  • DNP的新型非接触式透明屏幕可通过手的动作进行操作